Breathing easy with pathogen inactivation

Abstract

In this issue of Blood, Corash and colleagues report the results of a blinded expert analysis of patient experiences in the SPRINT trial of transfusion of pathogen-inactivated platelets and document the lack of any pulmonary toxicity of this approach to providing safer platelet transfusion.